Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
Showing: 1 - 1 of 1 results
  1. Treating Muscular Dystrophy with CRISPR Gene Editing

    Type
    Blog Post
    Published
    Jan. 26, 2016, 3:30 p.m.
    ...dystrophy (DMD), an X-linked recessive disorder affecting approximately 1 in 5000 males. DMD is caused ...difference in DMD, and it’s estimated that exon skipping therapies would be applicable to 80% of DMD patients...feasible case of DMD. If the safety and efficacy of this approach can be optimized, DMD could become one...age. Despite the amount of research conducted on DMD, there is still no good treatment. The dystrophin...be functional, exon skipping is a good option for DMD treatment. Clinical trials have used oligonucleotide...paired zinc finger nucleases to remove exon 51 in DMD patient myoblasts. They observed a 13% removal rate...exons 45-55 in patient myoblasts; when injected into DMD mice, these cells expressed functional dystrophin...
Showing: 1 - 1 of 1 results